oral or injectable tirzepatide Compound Oral Tirzepatide Pill: FDA-Approved Options

Tirzepatide-specific notes: Because it's a dual agonist with stronger effects on appetite, some people experience slightly more gastrointestinal side effects initially, particularly nausea

According to the Mounjaro Summary of Product Characteristics (SmPC), gastrointestinal disorders are very common side effects, with dyspepsia and gastro-oesophageal reflux disease specifically listed among the adverse reactions

A 2025 narrative review of clinical trials confirmed that across completed randomised and indirect comparisons, tirzepatide consistently outperforms semaglutide in body weight and HbA1c reduction [2]

11.03.25 More than 100 new plaintiffs joined the Mounjaro MDL There were 2,914 pending actions in the GLP-1 RA MDL as of November 3

In that role it is meant to reduce peptide breakdown during manufacturing, storage, and the weeks before use